ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Attention Disorders

• Publication date

  2017-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/1087054712474685PMID 23407278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial

  2014cited by this paper
• Attention-Deficit and Disruptive Behavior Disorders

  2014cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

  2010cited by this paper
• Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.

  2010influential reference
• Rebound Effects with Long-Acting Amphetamine or Methylphenidate Stimulant Medication Preparations among Adolescent Male Drivers with Attention-Deficit/Hyperactivity Disorder

  2008influential reference
• Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

  2007influential reference
• Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD: A Randomized, Controlled Trial

  2006cited by this paper
• Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

  2006cited by this paper
• ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  2006cited by this paper
• Emotional and Behavioral Difficulties and Impairments in Everyday Functioning Among Children With a History of Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment, 3rd ed.

  2006cited by this paper
• A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

  2004cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

  2004cited by this paper
• A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

  2003cited by this paper
• Stimulant Rebound: How Common Is It and What Does It Mean?

  2003influential reference
• Can Stimulant Rebound Mimic Pediatric Bipolar Disorder?

  2002cited by this paper
• Socioeconomic status as a moderator of ADHD treatment outcomes.

  2002cited by this paper
• Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

  2001cited by this paper
• Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

  2001cited by this paper
• Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

  2001cited by this paper
• A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

  2000cited by this paper
• Manic symptoms in psychiatrically hospitalized children--what do they mean?

  1998cited by this paper
• Analgesic Rebound Headache in Children and Adolescents

  1998cited by this paper
• Mania and ADHD: comorbidity or confusion.

  1998cited by this paper
• Caffeine dependence syndrome. Evidence from case histories and experimental evaluations.

  1994cited by this paper
• Attention Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment

  1991cited by this paper
• Psychostimulant rebound in attention deficit disordered boys.

  1988cited by this paper
• A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects.

  1983cited by this paper
• Benzodiazepine hypnotics remain effective for 24 weeks.

  1982cited by this paper
• “STIMULANTS.”

  1921cited by this paper
• Child and Adolescent Psychiatry and Mental Health a 13-hour Laboratory School Study of Lisdexamfetamine Dimesylate in School-aged Children with Attention-deficit/hyperactivity Disorder

  year unknowncited by this paper

• A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials

  2024cites this paper
• Caregivers’ engagement in pharmaceutical assessment and development: A systematic literature review

  2023cites this paper
• Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)

  2023influential citation
• A Dimensional Approach to Emotional Lability in Youth.

  2023cites this paper
• PPA_A_311836 1061..1073

  2021cites this paper
• Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment

  2021cites this paper
• High prevalence of ADHD symptoms in unmedicated youths with post-H1N1 narcolepsy type 1.

  2020cites this paper
• Stimulant Withdrawal in a Child with Autism Spectrum Disorder and ADHD - A Case Report.

  2018cites this paper
• The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD

  2018cites this paper
• Effect of Parent Management Training on Attention, Response Prevention, Impulsivity and Vigilance of Boys with Attention Deficient/Hyperactive Disorder

  2017cites this paper